KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -50.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 6,000 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -56.2% | 6,000 | 0.0% | 0.00% | – |
| Q3 2021 | $16,000 | -50.0% | 6,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $32,000 | -100.0% | 6,000 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $80,880,000 | +197168.3% | 12,000 | +100.0% | 0.00% | 0.0% |
| Q4 2020 | $41,000 | +78.3% | 6,000 | +100.0% | 0.00% | 0.0% |
| Q3 2020 | $23,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |